The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue†
John D. Puskas(Emory University Hospital Midtown), Joseph E. Bavaria(University of Pennsylvania), Michael E. Halkos(Emory University), Jacek Różański(Institute of Cardiology), Lars G. Svensson(Cleveland Clinic), Todd K. Rosengart(Baylor College of Medicine), James S. Gammie(Johns Hopkins University), Hiroo Takayama(Columbia University Irving Medical Center), Bartley P. Griffith(University of Maryland, Baltimore), Percy Boateng(Mount Sinai Medical Center), Tomasz A. Timek(Spectrum Health), Leonard N. Girardi(Cornell University), David Heimansohn, C.T. Klodell(University of Florida), Krzysztof Bartuś(Jagiellonian University), Douglas R. Johnston, William H. Ryan(Baylor Medical Center at Garland), Jerzy Sadowski(Jagiellonian University), Craig R. Smith(University of Arizona), Vaughn A. Starnes(Stanford Medicine), Shuab Omer(Michael E. DeBakey VA Medical Center), Eugene H. Blackstone(Cleveland Clinic), Mubashir Mumtaz(University of Pittsburgh Medical Center)
Cited by 89
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k